Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US09062X1037
Ticker BIIB
Company BIOGEN
Currency $
Price
Aware Investor Index (AII) 3.1875
Recommendation BUY
P/E 20.15
ROE 18.10 %
Capitalization 47,563,904,000 $
Dividend Yield 0.00 %
P/S 3.54
AII Position 179
P/E Position 292
ROE Position 183
Capitalization Position 184
Dividend Yield Position 594
Sales 13,452,900,000 $
10-Year Average Earnings 2,360,650,000 $
Shares Outstanding 205,300,000
Equity 13,039,600,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
BIOGEN Investor Relations Web Site http://investors.biogen.com/investor-relations







Sales:

YEAR MONTH AMOUNT
2018 12 13,452,900,000.00 $
2017 12 12,273,900,000.00 $
2016 12 11,448,800,000.00 $
2015 12 10,763,800,000.00 $
2014 12 9,703,300,000.00 $
2013 12 6,932,200,000.00 $
2011 12 5,516,500,000.00 $
2010 12 5,048,600,000.00 $
2009 12 4,716,400,000.00 $
2008 12 4,377,300,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 4,430,700,000.00 $
2017 12 2,539,100,000.00 $
2016 12 3,702,800,000.00 $
2015 12 3,547,000,000.00 $
2014 12 2,934,800,000.00 $
2013 12 1,862,300,000.00 $
2012 12 1,380,000,000.00 $
2011 12 1,234,400,000.00 $
2010 12 1,005,300,000.00 $
2009 12 970,100,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 13,039,600,000.00 $
2017 12 12,612,800,000.00 $
2016 12 12,140,000,000.00 $
2015 12 9,372,800,000.00 $
2014 12 10,809,000,000.00 $
2013 12 8,620,200,000.00 $
2012 12 6,961,500,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 205,300,000
2017 12 213,000,000
2016 12 218,800,000
2015 12 231,200,000
2014 12 237,200,000
2013 12 238,300,000
2012 12 239,700,000

 












Bloomberg News for BIOGEN:



Google News for BIOGEN:

NewsSmooth (press release) - 10 hours ago
Recent variation:: Biogen Inc., (NASDAQ: BIIB)
On Monday the USA Stock Exchange company, Biogen Inc., (NASDAQ: BIIB), the Trending-Graph. Each buying and selling session display ...
About Press Release (press release)
Are Investors Undervaluing Biogen (BIIB) Right Now?
One stock to keep an eye on is Biogen (BIIB). BIIB is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. Another ...
TechnoRecorder
Biogen and Invitae Announce Availability of Rapid Results in ...
20, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Invitae Corporation (NYSE: NVTA) today announced that SMA STAT, a new, ...
Finch News
How To Play Biogen Inc. (BIIB)'s Earnings Report
26 days have passed by since the last earnings report for Biogen Inc. (NASDAQ:BIIB) and the new quarterly results look set to arrive in 66 days.
Nasdaq - 6 days ago
Trend Indicator Watch on This Stock: Biogen Inc (BIIB)
After a recent look at shares of Biogen Inc (BIIB), we have seen that the Percentage Price Oscillator Histogram level is under zero. Traders ...
GlobeNewswire (press release) - 8 hours ago
Biogen Q2 Results Show Resilience
Biogen (BIIB) has been a long-term winning stock. Over shorter periods of time it has been very volatile. This stems partly from the binary nature ...
Seeking Alpha
3 Reasons Growth Investors Will Love Biogen (BIIB)
Biogen (BIIB) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a ...
DXC News - 1 day ago
Biogen (BIIB) Up on Q2 Earnings & Sales Beat, Raised View
Biogen Inc . BIIB reported second-quarter 2019 earnings per share of $9.15 which comprehensively beat the Zacks Consensus Estimate of ...
NewsSimatic (press release)
Brokers Issue Forecasts for Biogen Inc's FY2020 Earnings ...
Biogen Inc (NASDAQ:BIIB) – Svb Leerink raised their FY2020 earnings per share (EPS) estimates for shares of Biogen in a research note ...
Mayfield Recorder
Q1 2020 Earnings Estimate for Biogen Inc (NASDAQ:BIIB) Issued By ...
Biogen Inc (NASDAQ:BIIB) – Investment analysts at Wedbush lifted their Q1 2020 earnings per share estimates for shares of Biogen in a ...


Back